Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology
Clinical Trials: Parkinson's Disease
A listing of clinical trials currently looking for volunteers to enroll in Parkinson's Disease studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Alabaster : Neurology Neurodiagnostic Lab
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Birmingham :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Birmingham :
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Arizona
Sun City : Banner Sun Health Research Institute
A Double-blind, Placebo Controlled, Randomized, Multicenter Study to Assess the Safety and Clinical Benefit of Rasagiline as an Add on Therapy to Stable Dose of Dopamine Agonists in the Treatment of Early Parkinson’s Disease
Sun City : Banner Sun Health Research Institute
A Double-blind, Placebo Controlled, Randomized, Multicenter Study to Assess the Safety and Clinical Benefit of Rasagiline as an Add on Therapy to Stable Dose of Dopamine Agonists in the Treatment of Early Parkinson’s Disease
Sun City : Banner Sun Health Research Institute
A Double-blind, Placebo Controlled, Randomized, Multicenter Study to Assess the Safety and Clinical Benefit of Rasagiline as an Add on Therapy to Stable Dose of Dopamine Agonists in the Treatment of Early Parkinson’s Disease
Sun City : Banner Sun Health Research Institute
A Multi-center, double-blind, randomized, parallel-group, placebo-controlled study to assess the clinical effect of droxidopa in the treatment of symptomatic neurogenic orthostatic hypotension in patients with Parkinson's Disease
Sun City : Banner Sun Health Research Institute
A Phase 3, 12•Week, Double•Blind, Placebo-Controlled Efficacy and Safety Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease
Sun City : Banner Sun Health Research Institute
A Phase 3, Double-Blind, Double-Dummy, Placebo- and Active- Controlled Dose-Range-Finding Efficacy and Safety Study of Preladenant in Subjects With Early Parkinson's Disease (Phase 3 Protocol No. P05664)
Sun City : Banner Sun Health Research Institute
The Parkinson's Progression Markers Initiative (PPMI)
Tucson : Center for Neurosciences
Another day with Parkinson's Disease
View More »
Gilbert : Neurological Physicians of Arizona
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Phoenix : Teva Investigational Site 34
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Phoenix : Barrow Neurology Clinic
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Phoenix : Xenoscience
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Sun City : Research Site
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Sun City : Teva Investigational Site 42
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Sun City : Banner Health
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Tucson : Center for Neurosciences
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Arkansas
Little Rock : Clinical Trials, Inc.
Parkinson's Disease
View More »
Little Rock :
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
California
Fountain Valley : MMG Updated New
It takes a steady hand to manage life with Parkinson’s disease.
Pasadena : MMG Updated New
It takes a steady hand to manage life with Parkinson’s disease.
Reseda : MMG Updated New
It takes a steady hand to manage life with Parkinson’s disease.
Santa Rosa : Radiant Research - Santa Rosa
Clinical Research for Parkinson’s Disease
Ventura : MMG Updated New
It takes a steady hand to manage life with Parkinson’s disease.
View More »
Aliso Viejo : Avanir Pharmaceuticals
PRISM Registry: Pseudobulbar Affect Registry Series
Chicago :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Fountain Valley :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Fountain Valley : Teva Investigational Site 15
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Fresno : Teva Investigational Site 19
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
La Jolla : Coastal Neurological Medical Group
Carbidopa-Levodopa Extended-Release (CD-LD ER) Alone or in Combination With Carbidopa-Levodopa Immediate Release (IR) to IPX066 Followed by Extension Safety Study of IPX066 in Subjects With Advanced Parkinson's Disease
La Jolla : Teva Investigational Site 04
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
La Jolla :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Laguna Hills : Caring Clinical Research Incorporated
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Lancaster : Research Center for Clinical Studies West
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Loma Linda :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Long Beach :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Long Beach :
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Los Angeles :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Los Angeles :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Mountain View : Www.23Andme.Com/Pd
Web-based Genetic Research on Parkinson's Disease
Newport Beach : Hoag Memorial Hospital, Presbyterian
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Oxnard :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Oxnard :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Pasadena :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Pasadena : Neuro Therapeutics Incorporated
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Reseda :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Reseda : Neurosearch, Inc.
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
San Francisco : Teva Investigational Site 69
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
San Francisco :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
San Francisco : University of California, San Francisco
Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes
Sunnyvale : The Parkinson's Institute
A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients
Sunnyvale : The Parkinson's Institute
Carbidopa-Levodopa Extended-Release (CD-LD ER) Alone or in Combination With Carbidopa-Levodopa Immediate Release (IR) to IPX066 Followed by Extension Safety Study of IPX066 in Subjects With Advanced Parkinson's Disease
Sunnyvale :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Valencia : Sanguine Biosciences
A Biospecimen and Clinical Data Study on Patients With Alzheimer's, Multiple Sclerosis, Parkinson's, and Huntington's, for Drug & Biomarker Discovery
Ventura :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Ventura : Neurosearch II, Inc.
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Colorado
Boulder : Alpine Clinical Research Center
New Investigational Medication for Moderate to Severe Parkinson’s Disease
View More »
Denver :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Englewood : Colorado Neurology, P.C.
Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
Connecticut
Fairfield :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Fairfield : Teva Investigational Site 44
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Fairfield : Associated Neurologist of Southern Connecticut, PC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Hartford : Hartford Hospital
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Manchester : Teva Investigational Site 07
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
View More »
Manchester :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
New Haven :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Delaware
Newark : Teva Investigational Site 25
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Florida
Boca Raton : MMG Updated New
It takes a steady hand to manage life with Parkinson’s disease.
Miami : Pharmax Research Clinic, Inc.
Parkinson's Disease and feeling faint when stand up
Palm Beach Gardens : Palm Beach Neurological Center
Parkinson's Disease
View More »
Atlantis : Teva Investigative Site 63
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Boca Raton :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Boca Raton : Teva Investigational Site 30
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Boca Raton :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Boca Raton : Parkinson's Disease & Movement Disorder Disoder
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Bradenton :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Clearwater : Teva Investigational Site 13
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Gainsville :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Miami :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Miami : Pharmax Research Clinic, LLC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Ocala : Renstar Medical Research
Carbidopa-Levodopa Extended-Release (CD-LD ER) Alone or in Combination With Carbidopa-Levodopa Immediate Release (IR) to IPX066 Followed by Extension Safety Study of IPX066 in Subjects With Advanced Parkinson's Disease
Ormond Beach : Neurology Associates of Ormond Beach
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Port Charlotte :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Port Charlotte : Neurostudies Inc.
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Sarasota : Lovelace Scientific Research
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Sunrise : Teva Investigational Site 70
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Tampa :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Tampa : Teva Investigational Site 41
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Tampa :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Tampa : Tampa General University of South Florida
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Vero Beach : Vero Neurology
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
West Palm Beach : Premiere Research Institute
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Weston :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Georgia
Atlanta : Neurotrials Research, Inc.
Parkinson’s Disease
View More »
Atlanta :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Atlanta :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Atlanta : Emory University
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Augusta :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Augusta :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Idaho
Boise :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Illinois
Elk Grove Village : Alexian Brothers Hospital Network
A multicenter, double blind, randomized, parallel group, placebo controlled study to assess the clinical effect of Droxidopa in the treatment of symptomatic neurogenic orthostatis hypotension in patients with Parkinson's Disease
View More »
Chicago :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Chicago :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Chicago :
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Elk Grove Village : Alexian Brothers Hospital Network
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Springfield :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Winfield :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Indiana
Indianapolis : Teva Investigational Site 47
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Indianapolis : Teva Investigational Site 67
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Indianapolis : Teva Investigational Site 76
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Indianapolis :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Iowa
Des Moines :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Des Moines : Teva Investigational Site 55
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Des Moines :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Kansas
Kansas City :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Kansas City :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Kentucky
Lexington : Associates in Neurology, P.S.C.
A Phase 4 Study of Rasagiline or Placebo as an Add on Therapy to Stable Dose of Dopamine Agonists in the Treatment of Early Parkinson's Disease.
View More »
Lexington : Teva Investigational Site 17
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Lexington :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Louisiana
Hammond : North Oaks Health System
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Maryland
Baltimore :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Elkridge : Teva Investigational Site 62
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Elkridge :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Massachusetts
Boston :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Boston : Harvard Vanguard Medical Associates
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Springfield : Teva Investigational Site 51
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Michigan
Bingham Farms : QUEST Research Institute
Excessive Salivation (due to Parkinson' Disease) Study
Bingham Farms : Quest Research Institute
Parkinson's Disease - Paradyse Study
Bingham Farms : QUEST Research Institute
Phase II Parkinson' Disease Study evaluating a twice-daily oral investigational medicine compared to Sinemet.
View More »
Bingham Farms : Quest Research Institute
Carbidopa-Levodopa Extended-Release (CD-LD ER) Alone or in Combination With Carbidopa-Levodopa Immediate Release (IR) to IPX066 Followed by Extension Safety Study of IPX066 in Subjects With Advanced Parkinson's Disease
Bingham Farms :
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Detroit : Teva Investigational Site 11
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Traverse City : Northern Michigan Neurology
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
West Bloomfield :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
West Bloomfield : Teva Investigational Site 33
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
West Bloomfield :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Minnesota
Minneapolis :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Mississippi
Ocean Springs : Gulf Coast Neurology Center, PLLC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Missouri
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Parkinson’s disease patients and their caregivers are needed for a Washington University School of Medicine research study.
Saint Louis : Washington University in St. Louis - Center for Clinical Studies Updated New
Washington University seeks volunteers 60 – 85 years old for a Parkinson’s disease study.
View More »
St. Louis : Teva Investigational Site 22
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Montana
Missoula : Teva Investigational Site 59
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Nevada
Las Vegas : Teva Investigational Site 60
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Las Vegas : University of Nevada School of Medicine
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
New Jersey
New Brunswick : Robert Wood Johnson Medical School: University of Medicine & Dentistry of New Jersey
Barriers to Mental Health Care Utilization in Parkinson's Disease
New Brunswick : UMDNJ-Robert Wood Johnson Medical School
Coping With Depression in Parkinson's Disease
View More »
Belvidere : Wellness and Research Center
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Lawrenceville : AdvanceMed Research
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
New Brunswick :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Somerset : Teva Investigational Site 14
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Toms River :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Toms River : Shore Neurology
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
New York
Kingston : Biomedical Research Alliance of New York
Parkinson’s Disease - Adults
New Hyde Park : Parker Jewish Institute
Participate in a Clinical Trial for Parkinson’s Disease
New York : Biomedical Research Alliance of New York
Parkinson’s Disease - Adults
New York : Biomedical Research Alliance of New York
Parkinson’s Disease - Adults
View More »
Albany : Upstate Clinical Research, LLC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Comack :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Commack : Parkinson's Disease and Movement Disorders Center of Long Island
Carbidopa-Levodopa Extended-Release (CD-LD ER) Alone or in Combination With Carbidopa-Levodopa Immediate Release (IR) to IPX066 Followed by Extension Safety Study of IPX066 in Subjects With Advanced Parkinson's Disease
Commack :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Commack : Teva Investigational Site 03
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Commack : David L. Kreitzman, M.D., PC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Kingston : Kingston Neurological Associates
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
New Hyde Park : Parker Jewish Institute For Health Care and Rehabilitation Foundation
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
New York :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
New York :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
New York : New York University
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
New York : Beth Israel Medical Center
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Rochester : University of Rochester Medical Center
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
Syracuse : Neurological Care of CNY
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
North Carolina
Asheville : Teva Investigational Site 05
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Charlotte : Teva Investigational Site 31
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Durham :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Durham :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Raleigh :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
View More »
Raleigh : Teva Investigational Site 28
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Winston-Salem : Clinical Trials of America Inc
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Ohio
Cincinnati : MMG Updated New
It takes a steady hand to manage life with Parkinson’s disease.
Cincinnati : Community Research
Parkinson's Disease
View More »
Cincinnati : Teva Investigational Site 35
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Cincinnati : Teva Investigational Site 68
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Cincinnati :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Cincinnati :
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Cincinnati : Community Research
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Cleveland :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Columbus :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Columbus : Ohio State University Medical Center
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Toledo :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Toledo : University of Toledo
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Oklahoma
Tulsa :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Tulsa : Teva Investigational Site 64
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Tulsa :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Tulsa : Movement Disorder Clinic of Oklahoma PLLC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Oregon
Portland : Teva Investigational Site 40
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Pennsylvania
Allentown :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Johnstown : Ilumina Clinical Associates
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Philadelphia :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Pittsburgh : Clinical Trials Research Services LLC
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Rhode Island
Providence : Butler Hospital
The Effect of Rasagiline on Cognition in Parkinson's Disease
South Carolina
Charleston :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Tennessee
Cordova : Teva Investigative Site 65
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Nashville :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Texas
Dallas : Texas Neurology, PA
Clinical Research Study in Early Parkinson's Disease
View More »
Brownwood : Teva Investigational Site 71
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Dallas :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Dallas :
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Dallas : UT Southwestern Medical Center at Dallas
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Houston :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Houston :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
San Antonio :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
San Antonio : Teva Investigational Site 18
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Tyler :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Utah
Salt Lake City : JM Neuroscience Research
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Virginia
Richmond :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Richmond : Teva Investigational Site 09
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Richmond : Neurological Associates, Inc.
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Roanoke :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Virginia Beach : Teva Investigational Site 46
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
View More »
Virginia Beach : Sentara Neurology Specialists
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Washington
Kirkland :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Wisconsin
Madison : Teva Investigational Site 77
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Milwaukee : Wisconsin Institute for Neurologic and Sleep Disorders
Carbidopa-Levodopa Extended-Release (CD-LD ER) Alone or in Combination With Carbidopa-Levodopa Immediate Release (IR) to IPX066 Followed by Extension Safety Study of IPX066 in Subjects With Advanced Parkinson's Disease
Milwaukee :
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Milwaukee :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Argentina
Buenos Aires :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Santa Fe :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Austria
Innsbruck : Medizinische Universität Innsbruck - Klinik für Neurologie
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon
Vienna :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Vienna : Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Skodagasse 32, 1080 Vienna
Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease
Wien : Sozialmedizinisches Zentrum Ost - Donauspital, Neurologische Ambulanz
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon
Canada
Edmonton :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Halifax :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
London :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Montreal :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Ottawa :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
View More »
Quebec City :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Chile
Santiago :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Valdivia :
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
China
Guangzhou : CN003
Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
Shanghai : Renji Hospital Affiliated to Shanghai Jiaotong University, S
Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China
Shanghai : CN013
Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
Suzhou : CN006
Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
Wuhan : CN009
Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
View More »
Zi'an : CN014
Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
France
Montpellier :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Germany
Cologne :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Tübingen : Center of Neurology and Hertie Institute for Clinical Brain Research, and Department for Neurodegenerative Diseases, University of Tübingen
Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease
Israel
Petah Tikva : Rabin Medical Center
An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease
Ramat Gan : Sheba Medical Center
An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease
Tel Aviv : TASMC
An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease
Italy
Cagliari : IT010
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Chieti : IT007
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Genova : IT004
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Lido di Camaiore : IT005
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Messina : IT003
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
View More »
Milano : IT012
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Naples : IT001
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Pavia :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Roma : Università Cattolica - Policlinico Gemelli - Neurochirurgia Funzionale
Motor Cortex Stimulation for Parkinson's Disease
Roma : IT011
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Rome : IT008
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Torino : IT015
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Venezia : IT013
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Verona : IT009
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Japan
Tokyo : MSD K.K.
A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
Mexico
Tijuana : Hospital Angeles
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal in Patients With Parkinson's Disease
Spain
Alicante : 25
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Alicante : 27
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Barcelona : 48
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Barcelona : 52
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Barcelona : 47
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
View More »
Barcelona :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Bilbao : 55
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Ciudad Real : 32
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Granada : Clinical Nutrition and Dietetic Unit, University Hospital Virgen de las Nieves
Evaluation of a Diet in Patients With Senile Dementia
Granada : Department of Biochemistry and Molecular Biology II. University of Granada
Evaluation of a Diet in Patients With Senile Dementia
Jaen : 3
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Jaen : 4
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Lérida : 50
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Madrid : 75
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Madrid : 76
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Mao : 18
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Murcia : 81
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Murcia : 82
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Santa Cruz de Tenerife : 30
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Tenerife : 31
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Tenerife : 29
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Valencia : 24
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Valencia : 19
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Valencia : 20
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Vera de Bidasoa : 58
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
Sweden
Stockholm : Reserach Site
PET Study in Parkinson's Disease Patients
Vallingby : Research Site
PET Study in Parkinson's Disease Patients
Switzerland
Lugano : Neurocentro, Lugano
Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease
Zurich : University Hospital, Neurology
Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease
United Kingdom
London : Research site
To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers
Oxford :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
United States
Washington :
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
